# ANAKINRA IN THE TREATMENT OF PEDIATRIC ACUTE MYOCARDITIS

> **NCT07371689** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 110 (estimated)

## Conditions studied

- PEDIATRIC ACUTE MYOCARDITIS

## Interventions

- **DRUG:** Anakinra, KINERET®

## Key facts

- **NCT ID:** NCT07371689
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-02
- **Primary completion:** 2029-12
- **Final completion:** 2029-12
- **Target enrollment:** 110 (ESTIMATED)
- **Last updated:** 2026-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07371689

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07371689, "ANAKINRA IN THE TREATMENT OF PEDIATRIC ACUTE MYOCARDITIS". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT07371689. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*